{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T21:20:19Z","timestamp":1784236819842,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd006861.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,8,26]],"date-time":"2013-08-26T00:00:00Z","timestamp":1377475200000}}],"reference-count":125,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006861.pub3","type":"journal-article","created":{"date-parts":[[2013,8,26]],"date-time":"2013-08-26T20:41:07Z","timestamp":1377549667000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Interventions for erythropoietin-resistant anaemia in dialysis patients"],"prefix":"10.1002","volume":"2013","author":[{"given":"Sunil V","family":"Badve","sequence":"first","affiliation":[{"name":"Princess Alexandra Hospital; Department of Nephrology; Woolloongabba QLD Australia 4102"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine M","family":"Beller","sequence":"additional","affiliation":[{"name":"Bond University; Faculty of Health Sciences and Medicine; Gold Coast QLD Australia 4229"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Cass","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health; Renal and Metabolic Division; Level 10, King George V Building Royal Prince Alfred Hospital Camperdown NSW Australia 2050"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P","family":"Francis","sequence":"additional","affiliation":[{"name":"Queensland Health; Central Regional Services, Division of the CHO; Stafford DC QLD Australia 4053"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmel","family":"Hawley","sequence":"additional","affiliation":[{"name":"Princess Alexandra Hospital; Department of Nephrology; Woolloongabba QLD Australia 4102"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain C","family":"Macdougall","sequence":"additional","affiliation":[{"name":"King's College Hospital; Renal Unit; London UK SE5 9RS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlado","family":"Perkovic","sequence":"additional","affiliation":[{"name":"The George Institute for Global Health; Renal and Metabolic Division; Level 10, King George V Building Royal Prince Alfred Hospital Camperdown NSW Australia 2050"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W","family":"Johnson","sequence":"additional","affiliation":[{"name":"Princess Alexandra Hospital; Department of Nephrology; Woolloongabba QLD Australia 4102"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,8,26]]},"reference":[{"key":"10.1002\/14651858.CD006861.pub3-BIB0001|cit1","first-page":"488A","article-title":"Effect of intravenous ascorbic acid in hemodialysis patients with erythropoietin-hyporesponsive anemia and hyperferritenemia [abstract]","volume":"16","author":"Attallah","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD006861.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1053\/j.ajkd.2005.12.025","article-title":"Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia","volume":"47","author":"Attallah","year":"2006","journal-title":"American Journal of Kidney Diseases"},{"issue":"5","key":"10.1002\/14651858.CD006861.pub3-BIB0003|cit3","first-page":"701","article-title":"The effect of high-flux hemodialysis on renal anemia","volume":"17","author":"Ayli","year":"2004","journal-title":"Journal of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD006861.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1081\/JDI-42868","article-title":"The effect of high-flux hemodialysis on dialysis-associated amyloidosis","volume":"27","author":"Ayli","year":"2005","journal-title":"Renal Failure"},{"issue":"10","key":"10.1002\/14651858.CD006861.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1517\/14656566.2010.495119","article-title":"Clinical effectiveness and safety evaluation of long-term pioglitazone treatment for erythropoietin responsiveness and insulin resistance in type 2 diabetic patients on hemodialysis","volume":"11","author":"Abe","year":"2010","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"3","key":"10.1002\/14651858.CD006861.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00002216-198907000-00042","article-title":"Are high flux dialysis and erythropoietin treatment in a collision course?","volume":"35","author":"Acchiardo","year":"1989","journal-title":"ASAIO Transactions"},{"key":"10.1002\/14651858.CD006861.pub3-BIB0007|cit7","unstructured":"Aliev MA Ismagilov RZ Tsoy GM Yusumbaeva AS Influence of Eprex in combination with antihistamine drugs on correction of anemia in haemodialysis patients [abstract] 34th Congress European Renal Association\/European Dialysis and Transplantation Association; Geneva, Switzerland 1997 236"},{"issue":"1","key":"10.1002\/14651858.CD006861.pub3-BIB0008|cit8","first-page":"c82","article-title":"Effect of synthetic vitamin E-bonded membrane on responsiveness to erythropoiesis-stimulating agents in hemodialysis patients: a pilot study","volume":"115","author":"Andrulli","year":"2010","journal-title":"Nephron"},{"issue":"1","key":"10.1002\/14651858.CD006861.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0272-6386(12)80246-0","article-title":"Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease","volume":"17","author":"Ballal","year":"1991","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1002\/14651858.CD006861.pub3-BIB0010|cit10","first-page":"243A","article-title":"Treatment of anemia in hemodialysis patients to a normal hemoglobin concentration - results of an open randomized clinical trial of epoetin beta [abstract]","volume":"9","author":"Barany","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD006861.pub3-BIB0011|cit11","first-page":"264","article-title":"A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis","volume":"37","author":"Berns","year":"1992","journal-title":"Clinical Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD006861.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1053\/j.ajkd.2005.10.022","article-title":"Transdermal androgen therapy to augment EPO in the treatment of anemia of chronic renal disease","volume":"47","author":"Brockenbrough","year":"2006","journal-title":"American Journal of Kidney Diseases"},{"issue":"4","key":"10.1002\/14651858.CD006861.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000180834","article-title":"Effect of nandrolone decanoate on the anemia of chronic hemodialysis patients","volume":"18","author":"Buchwald","year":"1977","journal-title":"Nephron"},{"issue":"11","key":"10.1002\/14651858.CD006861.pub3-BIB0014|cit14","first-page":"891","article-title":"Effect of acupoint injection on erythropoietin resistance in patients with chronic renal failure","volume":"30","author":"Cao","year":"2010","journal-title":"Zhongguo Zhenjiu [Chinese Acupuncture & Moxibustion]"},{"issue":"8","key":"10.1002\/14651858.CD006861.pub3-BIB0015|cit15","first-page":"498","article-title":"Effects of L-carnitine on anemia in aged hemodialysis patients treated with recombinant human erythropoietin: A pilot study","volume":"27","author":"Caruso","year":"1998","journal-title":"Dialysis & Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD006861.pub3-BIB0016|cit16","first-page":"34","article-title":"The effect of hemodiafiltration with on-line endogenous reinfusion (on-line HFR) on anemia: design of a European, open, randomised, multicentre trial. European Collaborative Study","volume":"13","year":"2000","journal-title":"Journal of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD006861.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/ndt\/gfi154","article-title":"Effect of ascorbic acid supplementation on plasma isoprostanes in haemodialysis patients","volume":"21","author":"Chan","year":"2006","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD006861.pub3-BIB0018|cit18","first-page":"A80","article-title":"Efficacy and safety of oral compared with intravenous ascorbic acid in improving anaemia in erythropoietin hyporesponsive, iron overloaded, haemodialysis patients - a randomised open-label study [abstract]","volume":"8 Suppl 3","author":"Chan","year":"2003","journal-title":"Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD006861.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1440-1797.2005.00424.x","article-title":"Efficacy and safety of oral versus intravenous ascorbic acid for anaemia in haemodialysis patients","volume":"10","author":"Chan","year":"2005","journal-title":"Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD006861.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0272-6386(03)00419-0","article-title":"Effect of ascorbic acid administration in hemodialysis patients on in vitro oxidative stress parameters: influence of serum ferritin levels","volume":"42","author":"Chen","year":"2003","journal-title":"American Journal of Kidney Diseases"},{"issue":"6","key":"10.1002\/14651858.CD006861.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/039139880803100610","article-title":"Effect of vitamin E-coated dialysis membranes on anemia in patients with chronic kidney disease: an Italian multicenter study","volume":"31","author":"Cruz","year":"2008","journal-title":"International Journal of Artificial Organs"},{"issue":"11","key":"10.1002\/14651858.CD006861.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1001\/jama.298.11.1291","article-title":"Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial","volume":"298","author":"Culleton","year":"2007","journal-title":"JAMA"},{"issue":"Abstracts","key":"10.1002\/14651858.CD006861.pub3-BIB0023|cit23","first-page":"67A","article-title":"Nocturnal hemodialysis lowers blood pressure and reduces left ventricular mass: results of a randomized controlled trial [abstract]","volume":"18","author":"Culleton","year":"2007","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD006861.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2369-11-13","article-title":"Association between routine and standardized blood pressure measurements and left ventricular hypertrophy among patients on hemodialysis","volume":"11","author":"Khangura","year":"2010","journal-title":"BMC Nephrology"},{"issue":"Abstracts","key":"10.1002\/14651858.CD006861.pub3-BIB0025|cit25","first-page":"298A","article-title":"The impact of nocturnal hemodialysis on quality of life: results of a randomized controlled trial [abstract]","volume":"18","author":"Manns","year":"2007","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD006861.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/ki.2008.639","article-title":"Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis","volume":"75","author":"Manns","year":"2009","journal-title":"Kidney International"},{"issue":"3","key":"10.1002\/14651858.CD006861.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1053\/j.jrn.2010.04.004","article-title":"The effect of nocturnal and conventional hemodialysis on markers of nutritional status: results from a randomized trial","volume":"21","author":"Schorr","year":"2011","journal-title":"Journal of Renal Nutrition"},{"key":"10.1002\/14651858.CD006861.pub3-BIB0028|cit28","first-page":"734A","article-title":"Description of a randomized controlled trial on the effects of nocturnal hemodialysis on left ventricular hypertrophy compared to conventional hemodialysis [abstract]","volume":"16","author":"Walsh","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD006861.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2369-7-2","article-title":"The effects of nocturnal hemodialysis compared to conventional hemodialysis on change in left ventricular mass: rationale and study design of a randomized controlled pilot study","volume":"7","author":"Walsh","year":"2006","journal-title":"BMC Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD006861.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1542-4758.2009.00418.x","article-title":"The effects of nocturnal compared with conventional hemodialysis on mineral metabolism: a randomized-controlled trial","volume":"14","author":"Walsh","year":"2010","journal-title":"Hemodialysis International"},{"issue":"5","key":"10.1002\/14651858.CD006861.pub3-BIB0031|cit31","first-page":"703","article-title":"Comparative study of intravenous ascorbic acid versus low-dose desferroxamine in patients on hemodialysis with hyperferritinemia","volume":"16","author":"Deira","year":"2003","journal-title":"Journal of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD006861.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1523-1755.2004.404_2.x","article-title":"Supplemented very low-protein diet in advanced CRF: is it money saving?","volume":"65","author":"Iorio","year":"2004","journal-title":"Kidney International"},{"issue":"5","key":"10.1002\/14651858.CD006861.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1046\/j.1523-1755.2003.00282.x","article-title":"Supplemented very low protein diet ameliorates responsiveness to erythropoietin in chronic renal failure","volume":"64","author":"Iorio","year":"2003","journal-title":"Kidney International"},{"issue":"3","key":"10.1002\/14651858.CD006861.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/ndt\/gfl716","article-title":"Prevalence and predictors of epoetin hyporesponsiveness in chronic kidney disease patients","volume":"22","author":"Rossert","year":"2007","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Oct","key":"10.1002\/14651858.CD006861.pub3-BIB0035|cit35","first-page":"141A","article-title":"Prevalence and risk factors for erythropoetin hyporesponsiveness in chronic kidney disease: analysis of the ECAP study [abstract]","volume":"15","author":"Rossert","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Oct","key":"10.1002\/14651858.CD006861.pub3-BIB0036|cit36","first-page":"546A","article-title":"Effect of early correction of anemia on the progression of chronic kidney disease: final results ECAP study [abstract]","volume":"15","author":"Rossert","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD006861.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/j.ajkd.2006.02.170","article-title":"Effect of early correction of anemia on the progression of CKD","volume":"47","author":"Rossert","year":"2006","journal-title":"American Journal of Kidney Diseases"},{"issue":"Nov","key":"10.1002\/14651858.CD006861.pub3-BIB0038|cit38","first-page":"811A","article-title":"Effect on early correction of anemia on the progression of chronic kidney disease (ECAP) [abstract]","volume":"14","author":"Rossert","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD006861.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/039139880002300306","article-title":"The effect of hemodialysis and acetate-free biofiltration on anemia","volume":"23","author":"Eiselt","year":"2000","journal-title":"International Journal of Artificial Organs"},{"issue":"9","key":"10.1002\/14651858.CD006861.pub3-BIB0040|cit40","first-page":"A260","article-title":"Effects of biocompatible membranes on uremic anemia in hemodialysis patients [abstract]","volume":"14","author":"Garcia Cortes","year":"1999","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD006861.pub3-BIB0041|cit41","first-page":"370","article-title":"Beneficial effect of AN69 membranes on anemia in hemodialyzed patients","volume":"21","author":"Garcia Cortes","year":"2001","journal-title":"Nefrologia"},{"key":"10.1002\/14651858.CD006861.pub3-BIB0042|cit42","unstructured":"Garrote N Guinsburg M Garcia L Boubee S Moretto H Canale R Vitamin C improves HB levels and reduce EPO resistance in hemodialysis (HD) patients with functional iron deficiency (FID). A randomized, open label, controlled multicentric trial [abstract SA778] World Congress of Nephrology; 2009 May 22-26; Milan (Italy) 2009"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD006861.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/ndt\/10.supp6.44","article-title":"Resistance to erythropoietin in iron-overloaded haemodialysis patients can be overcome by ascorbic acid administration","volume":"10","author":"Gastaldello","year":"1995","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD006861.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0272-6386(97)90307-3","article-title":"A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients","volume":"30","author":"Gaughan","year":"1997","journal-title":"American Journal of Kidney Diseases"},{"issue":"9","key":"10.1002\/14651858.CD006861.pub3-BIB0045|cit45","first-page":"1490","article-title":"A six month study of low-dose recombinant human erythropoietin alone and in combination with androgen for the treatment of anemia in chronic hemodialysis patients [abstract]","volume":"7","author":"Liss","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD006861.pub3-BIB0046|cit46","first-page":"444","article-title":"Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial","volume":"13","author":"Giancaspro","year":"2000","journal-title":"Journal of Nephrology"},{"issue":"Suppl","key":"10.1002\/14651858.CD006861.pub3-BIB0047|cit47","first-page":"A314","article-title":"Intravenous ascorbic acid in comparison to intravenous iron in erythropoietin resistant anemia with iron overload in hemodialysis patients [abstract]","volume":"10","author":"Hakemi","year":"2005","journal-title":"Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD006861.pub3-BIB0048|cit48","first-page":"693","article-title":"Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients - a prospective cross-over study","volume":"17","author":"Hsu","year":"2004","journal-title":"Journal of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD006861.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1053\/j.ajkd.2005.02.020","article-title":"High-calorie supplementation increases serum leptin levels and improves response to rHuEPO in long-term hemodialysis patients","volume":"45","author":"Hung","year":"2005","journal-title":"American Journal of Kidney Diseases"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD006861.pub3-BIB0050|cit50","first-page":"332A","article-title":"Effect of Vitamin C on recombinant human erythropoietin refractory anemia in patients with chronic hemodialysis [abstract]","volume":"12","author":"Imada","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD006861.pub3-BIB0051|cit51","unstructured":"Comparison of the effect of erythropoietin, L-carnitine and erythropoietin plus L-carnitine in correction of anemia in chronic hemodialysis patients http:\/\/www.controlled-trials.com\/ISRCTN96315193\/ISRCTN96315193"},{"issue":"10","key":"10.1002\/14651858.CD006861.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/ncpneph0281","article-title":"Intravenous vitamin C can improve anemia in erythropoietin-hyporesponsive hemodialysis patients","volume":"2","author":"Jacobs","year":"2006","journal-title":"Nature Clinical Practice Nephrology"},{"issue":"12","key":"10.1002\/14651858.CD006861.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1093\/ndt\/10.12.2321","article-title":"Calcium acetate versus calcium carbonate and erythropoietin dosages in haemodialysis patients","volume":"10","author":"Janssen","year":"1995","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD006861.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1159\/000045860","article-title":"No effect of losartan on response to erythropoietin therapy in patients undergoing hemodialysis","volume":"86","author":"Kato","year":"2000","journal-title":"Nephron"},{"issue":"4","key":"10.1002\/14651858.CD006861.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0272-6386(03)00946-6","article-title":"Vitamin C for hyporesponsiveness to EPO: a cure for all?","volume":"42","author":"Deicher","year":"2003","journal-title":"American Journal of Kidney Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006861.pub3-BIB0056|cit56","first-page":"229","article-title":"The effect of intravenous vitamin C on erythropoietin response in haemodialysis patients [abstract]","volume":"17","author":"Keven","year":"2002","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD006861.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0272-6386(03)00356-1","article-title":"Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients","volume":"41","author":"Keven","year":"2003","journal-title":"American Journal of Kidney Diseases"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD006861.pub3-BIB0058|cit58","first-page":"357A","article-title":"The effect of Vitamin C on erythropoietin response in hemodialysis patients [abstract]","volume":"12","author":"Keven","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD006861.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00002480-200201000-00012","article-title":"Reduced requirement for erythropoietin with quotidian hemodialysis therapy","volume":"48","author":"Klarenbach","year":"2002","journal-title":"ASAIO Journal"},{"issue":"Suppl 69","key":"10.1002\/14651858.CD006861.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1038\/sj.ki.4490857","article-title":"Anemia and carnitine supplementation in hemodialyzed patients","volume":"55","author":"Kletzmayr","year":"1999","journal-title":"Kidney International - Supplement"},{"key":"10.1002\/14651858.CD006861.pub3-BIB0061|cit61","unstructured":"Koronis C Makris F Stavroulaki E Lambropoulou A Orthopoulos V Combination of low-dose recombinant human erythropoietin with androgens for the treatment of anaemia in hemodialysis patients [abstract] 37th Congress. European Renal Association. European Dialysis and Transplantation Association. European Kidney Research Organisation; Nice (France) 2000 235"},{"issue":"5","key":"10.1002\/14651858.CD006861.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0272-6386(95)90439-5","article-title":"L-carnitine effects on anemia in hemodialyzed patients treated with erythropoietin","volume":"26","author":"Labonia","year":"1995","journal-title":"American Journal of Kidney Diseases"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD006861.pub3-BIB0063|cit63","first-page":"358A","article-title":"Effects of adjuvant androgen on anemia and nutritional parameters in chronic hemodialysis patients using low-dose recombinant human erythropoietin [abstract]","volume":"12","author":"Lee","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD006861.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000059958","article-title":"Anemia of hemodialysis patients: evaluation of the effect of BK-F polymethylmethacrylate membrane","volume":"125","author":"Locatelli","year":"1999","journal-title":"Contributions to Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD006861.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/ndt\/15.9.1399","article-title":"Effect of high-flux dialysis on the anaemia of haemodialysis patients","volume":"15","author":"Locatelli","year":"2000","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD006861.pub3-BIB0066|cit66","first-page":"A156","article-title":"Does haemodialysis membrane's biocompatibility affect recombinant human erythropoietin (rHuEPO) effect on the anemia of hemodialyzed patients? [abstract]","volume":"15","author":"Malegos","year":"2000","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD006861.pub3-BIB0067|cit67","first-page":"2963","article-title":"Clinical studies of mepitiostane for treatment of anemia associated with chronic renal failure","volume":"24","author":"Miyahara","year":"1990","journal-title":"Kiso to Rinsho (The Clinical Report)"},{"issue":"1","key":"10.1002\/14651858.CD006861.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/jren.2003.50007","article-title":"Oral use of iron with vitamin C in hemodialyzed patients","volume":"13","author":"Mydl\u00edk","year":"2003","journal-title":"Journal of Renal Nutrition"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD006861.pub3-BIB0069|cit69","first-page":"S9","article-title":"Orally administrated Juzen-taiho-to\/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis","volume":"12","author":"Nakamoto","year":"2008","journal-title":"Hemodialysis International"},{"issue":"4","key":"10.1002\/14651858.CD006861.pub3-BIB0070|cit70","first-page":"715","article-title":"Effects of androgen therapy on hematologic and nutritional parameters in elderly peritoneal dialysis patients [abstract]","volume":"33","author":"Navarro","year":"2001","journal-title":"International Urology & Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD006861.pub3-BIB0071|cit71","first-page":"436A","article-title":"Prospective comparison between rHuEPO and androgens in CAPD patients: impact on hematologic and nutritional parameters [abstract]","volume":"12","author":"Navarro","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD006861.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1046\/j.1523-1755.2002.00271.x","article-title":"Randomized prospective comparison between erythropoietin and androgens in CAPD patients","volume":"61","author":"Navarro","year":"2002","journal-title":"Kidney International"},{"issue":"1","key":"10.1002\/14651858.CD006861.pub3-BIB0073|cit73","first-page":"59","article-title":"The effect of high dose losartan on erythropoietin resistance in patients undergoing haemodialysis","volume":"45","author":"Odabas","year":"2003","journal-title":"Panminerva medica"},{"issue":"5","key":"10.1002\/14651858.CD006861.pub3-BIB0074|cit74","first-page":"290","article-title":"Is folate supplementation necessary in hemodialysis patients on erythropoietin therapy","volume":"38","author":"Ono","year":"1992","journal-title":"Clinical Nephrology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD006861.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/00005344-198900133-00007","article-title":"Worsening of anemia by angiotensin converting enzyme inhibitors and its prevention by antiestrogenic steroid in chronic hemodialysis patients","volume":"13","author":"Onoyama","year":"1989","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"10","key":"10.1002\/14651858.CD006861.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1046\/j.1525-1594.1998.06107.x","article-title":"The effects of a polyacrylonitrile membrane and a membrane made of regenerated cellulose on the plasma concentrations of erythropoietin during hemodialysis","volume":"22","author":"Opatrn\u00fd","year":"1998","journal-title":"Artificial Organs"},{"key":"10.1002\/14651858.CD006861.pub3-BIB0077|cit77","unstructured":"Panichi V Barattini M Angelini D Petrone I Ferrandello FP Grazi G A vitamin E-coated polysulfone membrane reduces inflammatory markers and EPO requirement in haemodialysis patients [abstract SA413] World Congress of Nephrology; 2009 May 22-26; Milan (Italy) 2009"},{"issue":"1","key":"10.1002\/14651858.CD006861.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000321369","article-title":"A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial","volume":"32","author":"Panichi","year":"2011","journal-title":"Blood Purification"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD006861.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0272-6386(03)00533-X","article-title":"Management of anemia with quotidian hemodialysis","volume":"42","author":"Rao","year":"2003","journal-title":"American Journal of Kidney Diseases"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD006861.pub3-BIB0080|cit80","first-page":"240A","article-title":"Biocompatibility and erythropoiesis: - a randomised controlled, single center study of modified cellulose and polysulfone dialysers in a large hemodialysis cohort (n = 177) [abstract]","volume":"12","author":"Richardson","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD006861.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0272-6386(03)00788-1","article-title":"A randomized, controlled study of the consequences of hemodialysis membrane composition on erythropoietic response","volume":"42","author":"Richardson","year":"2003","journal-title":"American Journal of Kidney Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006861.pub3-BIB0082|cit82","first-page":"S310","article-title":"Effect of nandrolone deconoate on response to low dose erythropoietin (EPO) in anemia of end stage renal disease (ESRD) patients on maintenance hemodialysis (MHD) [abstract]","volume":"3","author":"Saxena","year":"1997","journal-title":"Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD006861.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1525-1594.2002.06888.x","article-title":"Intravenous ascorbic acid administration for erythropoietin-hyporesponsive anemia in iron loaded hemodialysis patients","volume":"26","author":"Sezer","year":"2002","journal-title":"Artificial Organs"},{"issue":"6","key":"10.1002\/14651858.CD006861.pub3-BIB0084|cit84","first-page":"933","article-title":"Effect of intravenous ascorbic acid in hemodialysis patients with anemia and hyperferritinemia","volume":"19","author":"Shahrbanoo","year":"2008","journal-title":"Saudi Journal of Kidney Diseases & Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD006861.pub3-BIB0085|cit85","first-page":"c102","article-title":"Use of nandrolone decanoate as an adjuvant for erythropoietin dose reduction in treating anemia in patients on hemodialysis","volume":"99","author":"Sheashaa","year":"2005","journal-title":"Nephron"},{"issue":"6","key":"10.1002\/14651858.CD006861.pub3-BIB0086|cit86","first-page":"A135","article-title":"Routine intravenous l-carnitine-supplementation does not reduce erythropoietin (RH-EPO)- requirement in chronic hemodialysis (CHD) patients (P) with renal anemia (RA)","volume":"16","author":"Sorge-Haedicke","year":"2001","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD006861.pub3-BIB0087|cit87","first-page":"537","article-title":"Effects of intravenous ascorbic acid on erythropoiesis and quality of life in unselected hemodialysis patients","volume":"17","author":"Taji","year":"2004","journal-title":"Journal of Nephrology"},{"issue":"11","key":"10.1002\/14651858.CD006861.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1093\/ndt\/13.11.2867","article-title":"A parallel, comparative study of intravenous iron versus intravenous ascorbic acid for erythropoietin-hyporesponsive anaemia in haemodialysis patients with iron overload","volume":"13","author":"Tarng","year":"1998","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD006861.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1046\/j.1523-1755.1999.00479.x","article-title":"Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia","volume":"55","author":"Tarng","year":"1999","journal-title":"Kidney International"},{"issue":"9","key":"10.1002\/14651858.CD006861.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1097\/01.ASN.0000137884.59308.E7","article-title":"Effect of intravenous ascorbic acid medication on serum levels of soluble transferrin receptor in hemodialysis patients","volume":"15","author":"Tarng","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD006861.pub3-BIB0091|cit91","first-page":"1051","article-title":"Faster improvement of the anemia in chronic hemodialysed patients with combined treatment with erythropoetin and essential amino acids ketoanalogues [abstract]","volume":"10","author":"Ursea","year":"1995","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD006861.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1053\/ajkd.2002.34919","article-title":"Effects of erythropoietin and vitamin E-modified membrane on plasma oxidative stress markers and anemia of hemodialyzed patients","volume":"40","author":"Usberti","year":"2002","journal-title":"American Journal of Kidney Diseases"},{"issue":"5","key":"10.1002\/14651858.CD006861.pub3-BIB0093|cit93","first-page":"558","article-title":"Effects of a vitamin E-bonded membrane and of glutathione on anemia and erythropoietin requirements in hemodialysis patients","volume":"15","author":"Usberti","year":"2002","journal-title":"Journal of Nephrology"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD006861.pub3-BIB0094|cit94","first-page":"v336","article-title":"Less need for erythropoietin in on-line haemodiafiltration compared to haemodialysis [abstract]","volume":"20","author":"Vaslaki","year":"2005","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD006861.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000090117","article-title":"On-line haemodiafiltration versus haemodialysis: stable haematocrit with less erythropoietin and improvement of other relevant blood parameters","volume":"24","author":"Vaslaki","year":"2006","journal-title":"Blood Purification"},{"issue":"11","key":"10.1002\/14651858.CD006861.pub3-BIB0096|cit96","first-page":"710","article-title":"Effect of high-dose folic acid on hemodialysis patients with poor erythropoietin response","volume":"29","author":"Wang","year":"2000","journal-title":"Dialysis & Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD006861.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/sj.ki.5000109","article-title":"Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress","volume":"69","author":"Yang","year":"2006","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD006861.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2369-9-8","article-title":"Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: a randomized controlled trial","volume":"9","author":"Johnson","year":"2008","journal-title":"BMC Nephrology"},{"key":"10.1002\/14651858.CD006861.pub3-BIB0099|cit99","unstructured":"Improvement of EPO-resistance in hemodialysis patients with chronic inflammation by high cut-off hemodialysis (CIEPO-PILOT) http:\/\/www.clinicaltrials.gov\/ct2\/results?term=NCT01526798"},{"issue":"2","key":"10.1002\/14651858.CD006861.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1440-1797.2010.01407.x","article-title":"Is the problem with the vehicle or the destination? Does high-dose ESA or high haemoglobin contribute to poor outcomes in CKD?","volume":"16","author":"Badve","year":"2011","journal-title":"Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD006861.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0272-6386(99)70015-6","article-title":"A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study)","volume":"34","author":"Benz","year":"1999","journal-title":"American Journal of Kidney Diseases"},{"issue":"9","key":"10.1002\/14651858.CD006861.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD006861.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/jama.2010.206","article-title":"Comparative mortality risk of anemia management practices in incident hemodialysis patients","volume":"303","author":"Brookhart","year":"2010","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD006861.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJM198907203210305","article-title":"Treatment of the anemia of progressive renal failure with recombinant human erythropoietin","volume":"321","author":"Eschbach","year":"1989","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006861.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2009.09.019","article-title":"Impact of erythropoiesis-stimulating agents on energy and physical function in nondialysis CKD patients with anemia: a systematic review","volume":"55","author":"Gandra","year":"2010","journal-title":"American Journal of Kidney Diseases"},{"issue":"7414","key":"10.1002\/14651858.CD006861.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006861.pub3-BIB0107|cit107","unstructured":"Higgins JP Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD006861.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/j.ajkd.2004.08.042","article-title":"Intractable anemia among hemodialysis patients: a sign of suboptimal management or a marker of disease?","volume":"45","author":"Kausz","year":"2005","journal-title":"American Journal of Kidney Diseases"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD006861.pub3-BIB0109|cit109","first-page":"S182","article-title":"NKF KDOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000","volume":"37","year":"2001","journal-title":"American Journal of Kidney Diseases"},{"issue":"5 Suppl 3","key":"10.1002\/14651858.CD006861.pub3-BIB0110|cit110","first-page":"S11","article-title":"KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease","volume":"47","author":"KDOQI. National Kidney Foundation","year":"2006","journal-title":"American Journal of Kidney Diseases"},{"issue":"4","key":"10.1002\/14651858.CD006861.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2215\/CJN.04601007","article-title":"Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients","volume":"3","author":"Kilpatrick","year":"2008","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD006861.pub3-BIB0112|cit112","first-page":"ii1","article-title":"Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure","volume":"19","author":"Locatelli","year":"2004","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD006861.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/ndt\/17.suppl_11.39","article-title":"Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines","volume":"17","author":"Macdougall","year":"2002","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD006861.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1053\/j.ajkd.2008.10.047","article-title":"Association of quarterly average achieved hematocrit with mortality in dialysis patients: a time-dependent comorbidity-adjusted model","volume":"53","author":"Messana","year":"2009","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"10.1002\/14651858.CD006861.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.7326\/0003-4819-153-1-201007060-00252","article-title":"Meta-analysis: Erythropoiesis-stimulating agents in patients with chronic kidney disease","volume":"153","author":"Palmer","year":"2010","journal-title":"Annals of Internal Medicine"},{"issue":"21","key":"10.1002\/14651858.CD006861.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"9559","key":"10.1002\/14651858.CD006861.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0140-6736(07)60194-9","article-title":"Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis","volume":"369","author":"Phrommintikul","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD006861.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1681\/ASN.2005090997","article-title":"Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients","volume":"17","author":"Regidor","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"20","key":"10.1002\/14651858.CD006861.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD006861.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1056\/NEJMoa1005109","article-title":"Erythropoietic response and outcomes in kidney disease and type 2 diabetes","volume":"363","author":"Solomon","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD006861.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/ki.2008.295","article-title":"Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes","volume":"74","author":"Szczech","year":"2008","journal-title":"Kidney International"},{"issue":"4","key":"10.1002\/14651858.CD006861.pub3-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/ki.1996.452","article-title":"Erythropoietin in chronic renal failure","volume":"50","author":"Valderrabano","year":"1996","journal-title":"Kidney International"},{"issue":"5","key":"10.1002\/14651858.CD006861.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0272-6386(04)01086-8","article-title":"Epoetin requirements predict mortality in hemodialysis patients","volume":"44","author":"Zhang","year":"2004","journal-title":"American Journal of Kidney Diseases"},{"issue":"3","key":"10.1002\/14651858.CD006861.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2215\/CJN.05071008","article-title":"Estimated effect of epoetin dosage on survival among elderly hemodialysis patients in the United States","volume":"4","author":"Zhang","year":"2009","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"issue":"1","key":"10.1002\/14651858.CD006861.pub3-BIB0125|cit125","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006861.pub2","article-title":"Interventions for erythropoietin-resistant anaemia in dialysis patients","author":"Badve","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD006861.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:14:29Z","timestamp":1734912869000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006861.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,26]]},"references-count":125,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006861.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,26]]}}}